Encube Ethicals Private Limited Clindamycin Export Data — India (DGFT 2022–2026)

Name: Encube Ethicals Private Limited Clindamycin Export Records India — #1 Exporter, 291 Shipments, $14.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

Encube Ethicals Private Limited — Clindamycin Exporter #1 | $14.6M Trade Value | TransData Nexus | TransData Nexus

Encube Ethicals Private Limited — Clindamycin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Clindamycin · $14.6M export value · DGFT Verified

Encube Ethicals Private Limited is the #1 Indian exporter of Clindamycin with $14.6M in export value and 291 verified shipments. Encube Ethicals Private Limited holds a 16.1% market share in Clindamycin exports across 6 countries. The company exports 11 pharmaceutical products worth $57.5M across 9 therapeutic categories.

Encube Ethicals Private Limited — Clindamycin Export Profile: Buyers & Destinations

Encube Ethicals Private Limited Clindamycin export treemap — buyers and destination countries | TransData Nexus

Where Does Encube Ethicals Private Limited Export Clindamycin?

Country	Value	Shipments	Share
UNITED STATES	$9.7M	278	94.6%
UNITED KINGDOM	$248.9K	8	2.4%
MALTA	$150.6K	4	1.5%
ISRAEL	$61.2K	2	0.6%
UNITED ARAB EMIRATES

Who Are the Top Buyers of Clindamycin from Encube Ethicals Private Limited?

Buyer	Country	Value	Orders
CARDINAL HEALTH	UNITED STATES	$3.3M	94
AIM RX 3PL, LLC	UNITED STATES	$2.2M	73
IPD, SC, USA	UNITED STATES	$2.2M	61
AIM RX 3PL LLC	UNITED STATES	$563.3K	14
IPD SC USA	UNITED STATES	$517.4K	13
MCKESSON THIRD PARTY LOGISTICS	UNITED STATES	$250.0K	5
MORNINGSIDE PHARMACEUTICALS LTD	UNITED KINGDOM	$219.9K	7
AIM RX 3PL,LLC	UNITED STATES	$200.8K	7
15 INGRAM BLVD LA VERGNE TENNESSEE	UNITED STATES	$128.4K	4
NORTHSTAR DISTRIBUTION CE	UNITED STATES	$101.4K	3

Encube Ethicals Private Limited supplies Clindamycin to 19 buyers globally. The largest buyer is CARDINAL HEALTH (UNITED STATES), followed by AIM RX 3PL, LLC (UNITED STATES) and IPD, SC, USA (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Clindamycin Formulations Does Encube Ethicals Private Limited Export?

Product Description / Formulation	Value	Shipments
CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U	$586.2K	19
CLINDAMYCIN PHOSPHATE TOP. LOT.1% 60ML (	$336.6K	9
CLINDAMYCIN (PHOSPHATE) GEL 1% 30GM (CLI	$263.3K	7
CLINDAMYCIN (PHOSPHATE) GEL 1% 60GM (CLI	$258.4K	9
CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDE	$250.0K	5
CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDEGEL, 1.2%/5% (45 GM) B.NO.3BF21 TO 3BF25 MFG DATE DEC 2023 EXP DATE NOV 2025NOS	$150.0K	3
CLINDAMYCIN PHOSPHATE TOPICAL LOTION, 1%,60ML B.NO.3CW27, 3CW26 MFG DATE DEC 2023 EXP DATE NOV 2025NOS	$150.0K	3
CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDEGEL, 1.2%/5% (45 GM) B.NO.4BF01 TO 4BF05 MFG DATE JAN 2024 EXP DATE DEC 2025NOS	$150.0K	3
CLINDAMYCIN PHOSPHATE TOPICAL LOTION 1%60ML (BATCH NO. 4CW39 4CW364CW384CW414CW434CW374CW454CW404CW444CW42 MFNOS	$150.0K	3
CLINDAMYCIN PHOSPHATE & BENZOYL PEROXIDEGEL,1.2%/5% (45 GM) B.No.4BF08,4BF10,4BF09,4BF11,4BF06,4BF07 MFG Dt.APR 2024 EX	$150.0K	3

Encube Ethicals Private Limited exports 178 distinct Clindamycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION U with 19 shipments worth $586.2K.

How Does Encube Ethicals Private Limited Compare to Nearest Clindamycin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	ENCUBE ETHICALS PRIVATE LIMITED ★	$14.6M	291	6	$50.0K
2	AUROBINDO PHARMA LTD	$9.4M	188	2	$50.0K
5	GLENMARK PHARMACEUTICALS LIMITED	$4.7M	199	6	$23.6K

Encube Ethicals Private Limited ranks #1 among 527 Indian Clindamycin exporters. Average shipment value of $50.0K compared to the market average of $90.3K. The closest competitors by value are AUROBINDO PHARMA LTD and GLENMARK PHARMACEUTICALS LIMITED.

Which Indian Ports Ship Clindamycin Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	1,184	16.3%
SAHAR AIR	1,119	15.5%
SAHAR AIR CARGO ACC (INBOM4)	966	13.3%
DELHI AIR	674	9.3%
NHAVA SHEVA SEA (INNSA1)	437	6.0%
JNPT/ NHAVA SHEVA SEA	328	4.5%
Bombay Air	309	4.3%
Delhi Air	201	2.8%

Geopolitical & Trade Policy Impact on Encube Ethicals Private Limited's Clindamycin Exports

Encube Ethicals' export operations are influenced by a complex interplay of geopolitical events and international trade policies. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Encube, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created opportunities for Indian pharmaceutical companies to capture a larger share of the U.S. market. Encube, with its FDA-approved facilities and established presence in the U.S., is well-positioned to leverage this shift. Additionally, the India-European Union Free Trade Agreement (FTA), concluded in January 2026, aims to eliminate tariffs on pharmaceuticals, thereby enhancing market access for Indian exporters. However, compliance with the EU's stringent regulatory standards, including the Falsified Medicines Directive, remains a critical factor for success in this market.

Encube Ethicals Private Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is paramount for Encube Ethicals. The company's adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) ensures the quality and safety of its products, facilitating access to global markets. The evolving regulatory landscape, particularly in the EU, necessitates continuous investment in quality systems and processes. For instance, the EU's requirement for analytical testing of every batch at the port of destination can delay market entry by two to three months. Proactive engagement with regulatory bodies and investment in compliance infrastructure are essential for mitigating such challenges.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Clindamycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Encube Ethicals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 296 individual customs records matching Encube Ethicals Private Limited exporting Clindamycin, covering 178 formulations to 6 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 144+ countries, 1,029+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Clindamycin

Clindamycin

Encube Ethicals Private Limited — Clindamycin Exporter Profile

Encube Ethicals Private Limited — Clindamycin Export Profile: Buyers & Destinations

Where Does Encube Ethicals Private Limited Export Clindamycin?

Who Are the Top Buyers of Clindamycin from Encube Ethicals Private Limited?

What Is India's Total Clindamycin Export Value and How Much Does Encube Ethicals Private Limited Contribute?

What Is the Average Shipment Value for Encube Ethicals Private Limited's Clindamycin Exports?

How Does Encube Ethicals Private Limited Compare to Other Indian Clindamycin Exporters?

What Clindamycin Formulations Does Encube Ethicals Private Limited Export?

Regulatory Requirements: Exporting Clindamycin to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Encube Ethicals Private Limited Compare to Nearest Clindamycin Exporters?

Which Indian Ports Ship Clindamycin Exports?

Clindamycin — Export Intelligence Video

Geopolitical & Trade Policy Impact on Encube Ethicals Private Limited's Clindamycin Exports

Encube Ethicals Private Limited — Regulatory Compliance & Quality Standards

About Encube Ethicals Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Clindamycin Export Data from Encube Ethicals Private Limited

Clindamycin Stats

Company Overview

Top Products by Encube Ethicals Private Limited

Related Analysis

Need Detailed Export Data?

Data Source